
Ceftrivox S 1000mg/500mg Injection
Marketer
Vnox Pharmaceuticals Pvt. Ltd.
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ceftrivox S 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a doctor's guidance; complete the prescribed regimen, even with symptom improvement, to maximize efficacy. Premature cessation can compromise treatment. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; severe reactions necessitate immediate medical attention. Allergic responses (rash, itching, edema, respiratory distress) require urgent medical care. Inform your physician of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally driving-safe, refrain from operating vehicles if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and sufficient hydration contribute to faster recovery. Monitoring via laboratory tests may be employed to assess treatment effectiveness.
Uses of Ceftrivox S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Ceftrivox S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftrivox S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftrivox S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ceftrivox S 1000mg/500mg Injection works:
Ceftrivox S, a 1000mg/500mg injectable formulation, unites the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Ceftrivox S 1000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftrivox S 1000mg/500mg Injection is typically regarded as safe. Preclinical trials in animals revealed minimal or no harm to fetuses; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Ceftrivox S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Ceftrivox S 1000mg/500mg Injection might cause drowsiness, blurred vision, or dizziness. Refrain from driving if experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftrivox S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Individuals with severe hepatic impairment should use Ceftrivox S 1000mg/500mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage changes for Ceftrivox S 1000mg/500mg Injection are unnecessary for those with mild to moderate liver dysfunction.
What if you forget to take Ceftrivox S 1000mg/500mg Injection :
Omit a Ceftrivox S 1000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Ceftrivox S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
